Evaluation of Treatment Strategies for Patients with Stage IIIA Non-Small Cell Lung Cancer in the Immunotherapy Era

被引：0
|
作者：
Alabaster, A. [1 ]
Velotta, J. B. [2 ]
Tupper, H. I. [3 ]
Natanzon, Y. [1 ]
机构：
[1] ConcertAI, Cambridge, MA USA
[2] Kaiser Permanente, Oakland, CA USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Stage IIIA; Surgery; Immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.02-34
引用
收藏
页码：S584 / S585
页数：2
相关论文
共 50 条
  • [41] Multidisciplinary Treatment for Stage IIIA Non-Small Cell Lung Cancer: Does Institution Type Matter?
    Samson, Pamela
    Patel, Aalok
    Crabtree, Traves D.
    Morgensztern, Daniel
    Robinson, Cliff G.
    Colditz, Graham A.
    Waqar, Saiama
    Kreisel, Daniel
    Krupnick, A. Sasha
    Patterson, G. Alexander
    Broderick, Stephen
    Meyers, Bryan F.
    Puri, Varun
    ANNALS OF THORACIC SURGERY, 2015, 100 (05): : 1773 - 1779
  • [42] Stage IIIA Non-Small Cell Lung Cancer Treatment and Outcomes: A Single Institution Retrospective Analysis
    Duan, R.
    Kwan, M.
    Kordon, A.
    Hu, C.
    Vanjani, N.
    Thomas, T. O.
    Patel, J. D.
    Yadav, P.
    Abazeed, M.
    Gharzai, L. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E16 - E16
  • [43] Role of radiotherapy in the treatment of stage IIIA/pN2 non-small cell lung cancer
    Jeremic, B.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S263 - S264
  • [44] Role of radiotherapy in the treatment of stage IIIA/pN2 non-small cell lung cancer
    Kaesmann, L.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S263 - S263
  • [45] Stage IIIA Non-Small Cell Lung Cancer Treatment and Outcomes: A Single Institution Retrospective Analysis
    Duan, Richard
    Kwan, Michelle
    Kordon, Avram
    Hu, Carolyn J.
    Vanjani, Nisheka
    Liu, Yingzhe
    Thomas, Tarita O.
    Gupta, Divya
    Patel, Jyoti
    Yadav, Poonam
    Abazeed, Mohamed E.
    Sun, Zequn
    Gharzai, Laila A.
    THORACIC CANCER, 2025, 16 (03)
  • [46] Treatment of stage III non-small cell lung cancer in the era of immunotherapy: pathological complete response to neoadjuvant pembrolizumab and chemotherapy
    Yang, Zhang-Ru
    Liu, Mi-Na
    Yu, Jia-Hua
    Yang, Yun-Hai
    Chen, Tian-Xiang
    Han, Yu-Chen
    Zhu, Lei
    Zhao, Ji-Kai
    Fu, Xiao-Long
    Cai, Xu-Wei
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (05) : 2059 - 2073
  • [47] Immunotherapy for non-small cell lung cancer: are we on the cusp of a new era?
    Waqar, Saiama N.
    Morgensztern, Daniel
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (08) : 871 - 873
  • [48] SURVIVAL OF PATIENTS WITH UNSUSPECTED N2 (STAGE IIIA) NON-SMALL CELL LUNG CANCER
    Park, Chang Kwon
    Lee, Deok Heon
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S883 - S883
  • [49] Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non-small cell lung cancer
    Cox, LS
    Sloan, JA
    Patten, CA
    Bonner, JA
    Geyer, SM
    McGinnis, WL
    Stella, PJ
    Marks, RS
    PSYCHO-ONCOLOGY, 2002, 11 (06) : 472 - 478
  • [50] Survival of Patients with Unsuspected N2 (Stage IIIA) Non-Small Cell Lung Cancer
    Yamamichi, Takashi
    Harada, Masahiko
    Hishima, Tsunekazu
    Asakawa, Ayaka
    Okui, Masayuki
    Horio, Hirotoshi
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S768 - S768
12345